Steven Cohen's FLGT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 236,954 shares of Fulgent Genetics, Inc. (FLGT) worth $6.22 M, representing 0.01% of the portfolio. First purchased in 2016-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in FLGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 508,692 shares. Largest reduction occurred in Q4 2021, reducing 180,295 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Fulgent Genetics (FLGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fulgent Genetics (FLGT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -134,307 | Reduce 36.18% | 236,954 | $26.27 |
| Q3 2025 | -173,616 | Reduce 31.86% | 371,261 | $22.60 |
| Q2 2025 | +508,692 | Add 1405.81% | 544,877 | $19.88 |
| Q1 2025 | -107,428 | Reduce 74.80% | 36,185 | $16.90 |
| Q4 2024 | -125,762 | Reduce 46.69% | 143,613 | $18.47 |
| Q3 2024 | +269,375 | New Buy | 269,375 | $21.73 |
| Q2 2024 | -81,800 | Sold Out | 0 | $0.00 |
| Q1 2024 | -69,513 | Reduce 45.94% | 81,800 | $21.70 |
| Q4 2023 | +148,913 | Add 6204.71% | 151,313 | $28.91 |
| Q3 2023 | +2,387 | Add 18361.54% | 2,400 | $26.74 |
| Q2 2023 | +13 | New Buy | 13 | $37.00 |
| Q1 2023 | -18,800 | Sold Out | 0 | $0.00 |
| Q4 2022 | -142,121 | Reduce 88.32% | 18,800 | $29.78 |
| Q3 2022 | -66,316 | Reduce 29.18% | 160,921 | $38.12 |
| Q2 2022 | +163,083 | Add 254.21% | 227,237 | $54.53 |
| Q1 2022 | +20,454 | Add 46.81% | 64,154 | $62.41 |
| Q4 2021 | -180,295 | Reduce 80.49% | 43,700 | $100.59 |
| Q3 2021 | +223,995 | New Buy | 223,995 | $89.95 |
| Q4 2016 | -80,000 | Sold Out | 0 | $0.00 |
| Q3 2016 | +80,000 | New Buy | 80,000 | $9.22 |
Steven Cohen's Fulgent Genetics Investment FAQs
Steven Cohen first purchased Fulgent Genetics, Inc. (FLGT) in Q3 2016, acquiring 80,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Fulgent Genetics, Inc. (FLGT) for 20 quarters since Q3 2016.
Steven Cohen's largest addition to Fulgent Genetics, Inc. (FLGT) was in Q2 2025, adding 544,877 shares worth $10.83 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 236,954 shares of Fulgent Genetics, Inc. (FLGT), valued at approximately $6.22 M.
As of the Q4 2025 filing, Fulgent Genetics, Inc. (FLGT) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Fulgent Genetics, Inc. (FLGT) was 544,877 shares, as reported at the end of Q2 2025.